Min Hospital has recently reached a cumulative 1,500 cases in bariatric and metabolic surgery, proving its extensive clinical capabilities in the fields of diabetes and metabolic disease treatment. Analysis shows that the hospital's systematic surgical strategies, based on precise candidate selection and customized approaches, have led to consistently stable treatment outcomes.
Min Hospital's metabolic surgery focuses on fundamental improvements of metabolic diseases, including type 2 diabetes, rather than simple weight loss. In fact, it has recorded an 87% complete remission rate in treatment outcomes for early-stage diabetes patients. This clinically demonstrates that metabolic surgery can be a practical alternative that goes beyond conventional medication. Above all, it received significant attention by introducing a precision process that applies the most appropriate surgical method after meticulously analyzing each patient's metabolic state and disease stage.
In particular, Min Hospital pioneered the field of surgery for pure diabetes treatment by being the first in Korea to introduce and implement Sleeve Gastrectomy-Ileal Bypass (SASI). Currently, it is regarded as a medical institution capable of performing all types of diabetes and metabolic procedures, including Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, Duodenal Switch, Jejunal Bypass, and Sleeve Gastrectomy-Ileal Bypass. This underscores the medical expertise required to treat a wide range of patients, from those with obesity to those suffering from diabetes.
The post-operative management system is another core competitive advantage of Min Hospital. It operates 24-hour 1:1 intensive care after surgery to prevent potential complications and support rapid recovery. Additionally, it maintains a stable surgical environment even for high-difficulty procedures, equipped with university hospital-grade laparoscopic-exclusive operating rooms and anesthesia equipment optimized for metabolic surgery. The fast-track system for patients residing in different regions also serves to increase treatment accessibility and efficiency.
Furthermore, Min Hospital's medical staff has been officially recognized for their contributions to the development of metabolic surgery in Korea, winning the Best Paper Award at the Korean Society for Metabolic and Bariatric Surgery. Systematic treatment systems are consistently being maintained as an accredited medical institution for bariatric and metabolic surgery, with specialized medical staff led by Director Kim Jong-min and Director Seong Jong-je, who are certified surgeons in the field.
Director Kim Jong-min of Min Hospital stated, "Taking this achievement of 1,500 cases as a base, we plan to continue presenting new standards for obesity and diabetes treatment through a medical system that encompasses accurate candidate selection, customized surgery, and comprehensive post-operative care."